Navigation Links
Schizophrenia Patients Who Take Antipsychotics Live Longer, Study Says
Date:11/14/2012

WEDNESDAY, Nov. 14 (HealthDay News) -- People with schizophrenia are likely to live longer if they take their antipsychotic drugs on schedule, avoid extremely high doses and have regular visits with a mental-health professional, according to a new study.

It's long been known that adhering to a drug regimen reduces the number of the delusions and hallucinations experienced by schizophrenia patients, but there have been concerns that known physical side effects of the medications -- such as diabetes and heart disease -- might increase the risk of death.

In this study, researchers analyzed data collected from 1994 to 2004 on more than 2,100 adult schizophrenia patients in Maryland. The most common cause of death was cardiovascular disease, which was responsible for 28 percent of patient deaths. Unintended harm, in which researchers included suicide, caused 8 percent of patient deaths during the study period.

Patients with a 90 percent or better compliance with their antipsychotic medication regimen had a 25 percent lower risk of death than those with a compliance of less than 10 percent.

The researchers also found that each additional visit per year to a mental-health professional was associated with a 5 percent reduction in overall death risk.

Although sticking with an antipsychotic drug regimen reduced the risk of death, the researchers found that patients who took high doses of first-generation antipsychotics daily had an 88 percent increased risk of death.

First-generation antipsychotics have been linked with heart disease risks, and among the patients who died in the study while taking larger doses, 53 percent died of cardiovascular disease.

"These drugs work very well, but there is clearly a point of diminishing returns. You rarely need to be on extremely high doses," study leader Bernadette Cullen, assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, in Baltimore, said in a university news release.

The study was published online Oct. 30 in the journal Schizophrenia Bulletin.

"We know that antipsychotic medications reduce symptoms, and our study shows that staying on reasonable, recommended doses is associated with longer life," Cullen said. "The same is true for going to see a psychiatrist or therapist."

Cullen noted that regular visits to a mental-health professional are one way to monitor and encourage drug-use compliance, but also in and of themselves increase survival among schizophrenia patients.

"If people are taking their medications, they usually have fewer symptoms and are able to be more organized in other areas of their lives," said Cullen, who also is director of community psychiatry at the Johns Hopkins Hospital.

"We believe they are then more likely to make appointments with their primary care doctors, to stay on top of other illnesses they may have and to regularly take diabetes, blood pressure or cholesterol medication that they may require to stay healthy," she said. "We also believe that they are more likely to be socially engaged and have a healthier lifestyle."

Although the researchers found an association between strict antipsychotic drug regimens and longer life among people with schizophrenia, they did not prove a cause-and-effect relationship.

More information

The U.S. National Institute of Mental Health has more about schizophrenia.

-- Robert Preidt

SOURCE: Johns Hopkins Medicine, news release, November 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study: Use of antipsychotic drugs improves life expectancy for individuals with schizophrenia
2. Older Dads May Raise Risk for Autism, Schizophrenia in Kids
3. Schizophrenia in Movies: Dont Believe Everything You See
4. Using biomarkers to identify and treat schizophrenia
5. Mount Sinai finds common factors in autism spectrum disorders, schizophrenia, and bipolar disorder
6. Family History of Schizophrenia, Bipolar Disorder May Up Kids Risk for Autism
7. Feinstein Institute to Receive Grant from Centers for Medicare & Medicaid Services to Improve Schizophrenia Treatment
8. Feinstein Institute to receive grant to improve schizophrenia treatment
9. Fewer suicides after antidepressive treatment for schizophrenia
10. Antipsychotics Do Help Many With Schizophrenia, Study Finds
11. Genes Associated With Autism Also Related to Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Schizophrenia Patients Who Take Antipsychotics Live Longer, Study Says
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/7/2017)... --  Provista, a proven leader in the supply ... power, today announced a new resource area on Provistaco.com ... is the online home for case studies, articles on ... releases, slideshows and events. ... at their fingertips, viewers can also watch short videos ...
Breaking Medicine Technology: